FDG-PET for evaluating musculoskeletal tumors: a review
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 8 (3) , 435-441
- https://doi.org/10.1007/s10776-001-0539-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue massesSkeletal Radiology, 2003
- FDG PET of Primary Benign and Malignant Bone Tumors: Standardized Uptake Value in 52 LesionsRadiology, 2001
- PET imaging in oncologySeminars in Nuclear Medicine, 2000
- Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings.Radiology, 1998
- PET in oncology: Will it replace the other modalities?Seminars in Nuclear Medicine, 1997
- Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucoseAnnals of Surgical Oncology, 1997
- Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose.Radiology, 1996
- Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1995
- PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose.Radiology, 1992
- A System for the Surgical Staging of Musculoskeletal SarcomaClinical Orthopaedics and Related Research, 1980